Conservative Management of Chronic Pancreatitis

  • E. P. DiMagno
Conference paper

Abstract

Pain and the symptoms of malabsorption are the cardinal manifestations of chronic pancreatitis that require treatment. Complications such as bile duct obstruction secondary to fibrosis or intrapancreatic retention cysts and pseudocysts may also arise and require treatment.

Keywords

Lipase Aspirin Pancreatitis Diarrhea Trypsin 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    DiMagno EP, Ciain JE (1986) Chronic pancreatitis. In: Go VLW, Gardner JD, Brooks FP, Lebenthal E, DiMagno EP, Scheele GA (eds) The exocrine pancreas: biology, pathobiology and diseases. Raven, New York, pp 541–575Google Scholar
  2. 2.
    Ammann RW, Buehler H, Muench R, Freiburghaus AW, Siegenthaler W (1987) Differences in the natural history of idiopathic (nonalcoholic) and alcoholic chronic pancreatitis. A comparative long-term study of 287 patients. Pancreas 2:368–377PubMedCrossRefGoogle Scholar
  3. 3.
    Layer P, Kalthoff L, Ciain JE, DiMagno EP (1985) Nonalcoholic chronic pancreatitis — two diseases? Dig Dis Sci 30:980Google Scholar
  4. 4.
    Owyang C (1989) Control of exocrine pancreatic secretion. Regul Pept 1:1–7Google Scholar
  5. 5.
    Rowell WG, Toskes PP (1989) Pain in chronic pancreatitis. In: Barkin J, Rogers A (eds) Difficult decisions in digestive diseases. Yearbook Medical, Chicago, pp 192–197Google Scholar
  6. 6.
    Boivin M, Lanspa SJ, Zinsmeister AR, Go VLW, DiMagno EP (1990) Are diets associated with different rates of human interdigestive and postprandial pancreatic enzyme secretion? Gastroenterology 99:1763–1771PubMedGoogle Scholar
  7. 7.
    Pap A, Nauss LA, DiMagno EP (1990) Is percutaneous celiac plexus block (PCPB) associated with pain relief in chronic pancreatitis? A comparison among analgesic, alcohol and steroid PCPB. Pancreas 5:725Google Scholar
  8. 8.
    Bengtsson M, Lofstrom JB (1990) Nerve block in pancreatic pain. Acta Chir Scand 156:285–291PubMedGoogle Scholar
  9. 9.
    Ihse I, Permerth J (1990) Enzyme therapy and pancreatic pain. Acta Chir Scand 156:281–283PubMedGoogle Scholar
  10. 10.
    Huibregtse K, Schneider B, Vrij AA, Tytgat (1988) Endoscopic pancreatic drainage in chronic pancreatitis. Gastrointest Endosc 34:9–15PubMedCrossRefGoogle Scholar
  11. 11.
    McCarthy J, Geenen JE, Hogan WJ (1988) Preliminary experience with endoscopic stent placement in benign pancreatic diseases. Gastrointest Endosc 34:16–18PubMedCrossRefGoogle Scholar
  12. 12.
    Kozarek RE (1989) Pancreatic stents can induce ductal changes consistent with chronic pancreatitis. Gastrointest Endosc 35.A170Google Scholar
  13. 13.
    Derfus GA, Geenen JE, Hogan WJ (1989) Alterations in pancreatic duct morphology associated with endoscopic stent placement. Pancreas 4:613Google Scholar
  14. 14.
    Regan PT, Malagelada J-R, DiMagno EP, Glanzman SL, and Go VLW (1977) Comparative effects of antacids, Cimetidine, and enteric coating on the therapeutic response to oral enzymes in severe pancreatic insufficiency. N Engl J Med 297:854–858PubMedCrossRefGoogle Scholar
  15. 15.
    Regan PT, Malagelada J-R, DiMagno EP, Go VLW (1979) Reduced intraluminal bile acid concentrations and fat maldigestion in pancreatic insufficiency: correction by treatment. Gastroenterology 77:285–289PubMedGoogle Scholar
  16. 16.
    Thiruvengadam R, DiMagno EP (1988) Inactivation of human lipase by proteases. Am J Physiol 255:G476-G481PubMedGoogle Scholar
  17. 17.
    Mundlos S, Kühnelt P, Adler G (1990) Monitoring enzyme replacement treatment in exocrine pancreatic insufficiency using the cholesteryl octanoate breath test. Gut 31:1324–1328PubMedCrossRefGoogle Scholar
  18. 18.
    Andersen JR, Bendtsen F, Ovesen L, Pedersen NT, Rune SJ, Tage-Jensen U (1990) Pancreatic insufficiency. Duodenal and jejunal pH, bile acid activity, and micellar lipid solubilization. Int J Pancreatol 6:263–270PubMedGoogle Scholar
  19. 19.
    Kelly DG, Sternby B, DiMagno EP (1991) How to protect human pancreatic enzyme activities in frozen duodenal juice. Gastroenterology 100:189–195PubMedGoogle Scholar
  20. 20.
    Graham DY (1982) Pancreatic enzyme replacement: the effect of antacids or Cimetidine. Dig Dis Sci 27:485–490PubMedCrossRefGoogle Scholar
  21. Schneider MU, Knoll-Ruzicka ML, Domschke S, Heptner G, Domschke W (1985) Pancreatic enzyme replacement therapy: comparative effects of conventional and enteric-coated microspheric pancreatin and acid-stable fungal enzyme preparations on steatorrhoea in chronic pancreatitis. Hepatogastroenterology 32:97–102PubMedGoogle Scholar
  22. 22.
    Robinson PJ, Sly PD (1990) High-dose pancreatic enzymes in cystic fibrosis. Arch Dis Child 65:311–312PubMedCrossRefGoogle Scholar
  23. 23.
    Williams J, MacDonald A, Weller PH, Fields J, Pandov H (1990) Two enteric coated microspheres in cystic fibrosis. Arch Dis Child 65:594–597PubMedCrossRefGoogle Scholar
  24. 24.
    Jorgensen BB, Thorsgaard Pedersen N, Worning H (1991) Monitoring the effect of substitution therapy in patients with exocrine pancreatic insufficiency. Scand J Gastroenterol 26:321–326PubMedCrossRefGoogle Scholar
  25. 25.
    Hendeles L, Dorf A, Stecenko A, Weinberger M (1990) Treatment failure after substitution of generic pancrelipase capsules. JAMA 263:2459–2461PubMedCrossRefGoogle Scholar
  26. 26.
    Gullo L, Parenti M, Monti L, Pezzilli R, Barbara L (1990) Diabetic retinopathy in chronic pancreatitis. Gastroenterology 98:1577–1581PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1993

Authors and Affiliations

  • E. P. DiMagno
    • 1
  1. 1.GI UnitMayo ClinicRochesterUSA

Personalised recommendations